Arcellx
Arcellx is a biotechnology company focused on reimagining cell therapy for patients with cancer and other incurable diseases. They are seeking a candidate to support the development and optimization of protein glycan analysis methods and assist with protein characterization projects, contributing to innovative immunotherapies.
Arcellx is a biopharmaceutical company developing next‑generation cell therapies for cancer and autoimmune diseases. With a proprietary technology platform, they aim to reimagine and "supercharge" cell therapy to pursue cures and improve patient outcomes. The company advances engineered cell therapy candidates through research and clinical development to address unmet medical needs. Arcellx emphasizes innovation in therapeutic design and clinical translation.
Headquarters
San Francisco, CA
Company Size
201-500 employees
Founded
2018
Industry
Technology
Glassdoor Rating
4.2 / 5
Sarah Johnson
Chief Executive Officer
Michael Chen
Chief Technology Officer
Emily Williams
VP of Engineering
David Rodriguez
VP of Product
Jessica Thompson
Chief Financial Officer
Andrew Park
VP of Sales
View leadership team, funding history,
and employee contacts for Arcellx.
Arcellx didn’t post a salary, so this is our estimate from similar listings.
Gilead to buy Arcellx in nearly $8B deal
2 weeks ago
Scientist/ Sr. Scientist - Biologics Analytical Sciences
Zoetis
Protein Analytics Scientist
Bristol Myers Squibb
Analytical Scientist, Ph.D.
Pivotal
Senior Scientist, Analytical Development
CSL
Analytical Scientist (Permanent-fulltime)
Integrated Resources INC
Analytical Scientist (Permanent-fulltime)
Integrated Resources INC